| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.017 | 0.8 |